What is pleural tapping (thoracentesis) and how is it performed in patients with pleural effusion, particularly those with underlying conditions such as lung disease, heart failure, or cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pleural Tapping (Thoracentesis): Comprehensive Clinical Guide

Definition and Purpose

Thoracentesis is an invasive procedure involving needle insertion into the pleural space to aspirate fluid for diagnostic evaluation or therapeutic relief of dyspnea, and should always be performed with ultrasound guidance to minimize complications. 1

The procedure serves two primary functions:

  • Diagnostic: Determining etiology of undiagnosed unilateral pleural effusion or bilateral effusion with normal heart size, particularly for suspected malignancy requiring cytological examination 1
  • Therapeutic: Relief of dyspnea in symptomatic pleural effusions, especially recurrent malignant effusions causing respiratory compromise 1

Pre-Procedure Assessment

Imaging Requirements

Ultrasound examination immediately before the procedure is mandatory to accurately locate fluid, identify loculations or septations, and mark the optimal insertion site 1. This reduces pneumothorax risk by 90% (from 8.9% to 1.0% in malignant effusions) 1.

Key imaging assessments include:

  • Chest radiography to determine effusion size, laterality, and presence of mediastinal shift 1
  • Real-time ultrasound to identify intercostal vessels and decrease hemorrhagic complications 1
  • Assessment of mediastinal shift direction: Ipsilateral shift suggests trapped lung or endobronchial obstruction, making fluid removal unlikely to relieve dyspnea 2

Patient Selection

Asymptomatic patients with malignant pleural effusion should not undergo routine drainage, as observational data shows these patients rarely require intervention during follow-up 1.

Procedure Technique

Site Selection and Approach

Use ultrasound to identify the insertion site in real-time, typically in the mid-scapular or posterior axillary line, one to two intercostal spaces below the upper border of the effusion 1.

For diagnostic thoracentesis with small volumes:

  • Use small-gauge needles (21 or 22 gauge) when removing 35-50 mL to minimize pneumothorax risk 3
  • Obtain at least 25 mL (ideally 50 mL) of pleural fluid for cytological examination 1

Volume Limitations and Safety Monitoring

Limit initial fluid removal to 1-1.5 L unless pleural pressure monitoring is available to minimize re-expansion pulmonary edema risk (incidence 0.5-2.2%) 2.

Pleural Pressure Monitoring Protocol

When using manometry:

  • Stop if pleural pressure drops below -20 cm H₂O during fluid removal 2
  • Pressure >19 cm H₂O with removal of 500 mL or >20 cm H₂O with removal of 1 L predicts trapped lung 1
  • If pressure remains above -20 cm H₂O, fluid removal can usually continue safely 2

Clinical Symptom Monitoring

Stop immediately if the patient develops dyspnea, chest pain, or severe cough during the procedure 2. However, recognize that neither patient nor operator may be aware of precipitous pressure decreases, making symptoms an unreliable sole indicator 2.

When contralateral mediastinal shift is present and the patient tolerates thoracentesis without symptoms, removal of several liters is probably safe 2.

Contraindications

Relative Contraindications

The following conditions require careful risk-benefit assessment 1:

  • Minimal effusion volume
  • Bleeding diathesis or anticoagulation
  • Mechanical ventilation (though patients on ventilators have no greater morbidity than non-ventilated patients) 3
  • Severe renal failure

Complications and Prevention

Pneumothorax

Ultrasound guidance reduces pneumothorax risk by 19% overall (from 6.0% baseline in meta-analysis of 6,605 thoracenteses) 1. The most critical prevention strategy is avoiding blind thoracentesis 1, 2.

Re-Expansion Pulmonary Edema

Re-expansion pulmonary edema is caused by excessively negative pleural pressure generation rather than volume removed, related to increased capillary permeability from mechanical forces and ischemia-reperfusion injury 2.

Prevention algorithm:

  1. Assess chest radiograph for mediastinal shift direction before starting 2
  2. Monitor for warning symptoms continuously 2
  3. Limit volume to 1-1.5 L without manometry 2
  4. Obtain post-procedure chest radiograph to evaluate lung re-expansion 2
  5. Monitor for delayed pulmonary edema, which can occur hours after the procedure 2

Hemorrhagic Complications

Ultrasound identification of intercostal vessels decreases hemorrhagic complications 1. Chest tube placement was required in 2.2% of non-ultrasound-guided procedures versus 0% with ultrasound guidance 1.

Other Complications to Monitor

Monitor for bleeding, infection, and solid organ laceration throughout and after the procedure 1.

Special Populations and Conditions

Malignant Pleural Effusions

Nonexpandable lung occurs in at least 30% of patients with malignant pleural effusions and may contraindicate pleurodesis 1. These patients have significantly shorter median survival (7.5 vs. 12.7 months) 1.

Ultrasound evaluation before thoracentesis can identify nonexpandable lung, guiding definitive management decisions 1.

Trapped Lung Recognition

Critical indicators of trapped lung include:

  • Lack of mediastinal shift on initial chest radiograph despite large effusion 4
  • Initial pleural pressure <-10 cm H₂O at thoracentesis 4
  • Pressure >19-20 cm H₂O with removal of 500 mL to 1 L 1
  • Failure of complete lung expansion after drainage despite adequate tube function 4

Recurrent Effusions

For recurrent malignant effusions, consider more definitive interventions such as chemical pleurodesis 1. Palliative therapy with periodic outpatient thoracentesis is appropriate for patients with far advanced disease and poor performance status 1.

Post-Procedure Management

Immediate Assessment

If dyspnea is not relieved after thoracentesis, investigate alternative causes 1:

  • Lymphangitic carcinomatosis
  • Atelectasis
  • Thromboembolism
  • Tumor embolism
  • Endobronchial obstruction

Chest Tube Management (When Placed)

Remove chest tube when 24-hour drainage volume is <250-300 mL/day of non-sanguineous fluid, no air leaks are present, and chest radiograph demonstrates complete or near-complete lung expansion 4.

Maintain suction drainage at -20 cm H₂O until output decreases to acceptable levels 4. Output of 150 mL/hour is elevated but does not automatically require intervention beyond continued drainage 4.

Critical Pitfalls to Avoid

  1. Never perform blind thoracentesis without ultrasound guidance 1, 2
  2. Do not remove chest tubes prematurely if trapped lung is suspected 4
  3. Do not rely solely on radiographic lung re-expansion as a surrogate for normal pleural elastance: radiographic expansion has only 44% sensitivity and 24% positive predictive value for normal terminal pleural elastance, with 71% of radiographically expanded lungs showing abnormal visceral pleural recoil 5
  4. Do not continue fluid removal if pleural pressure drops below -20 cm H₂O 2
  5. Recognize that ipsilateral mediastinal shift indicates trapped lung or bronchial obstruction, making symptom relief unlikely 2

References

Guideline

Indications for Thoracentesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Re-Expansion Pulmonary Edema Following Thoracentesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Thoracentesis in clinical practice.

Heart & lung : the journal of critical care, 1994

Guideline

Management of Elevated Chest Tube Output Post-Thoracentesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.